Closing Wrap - Friday 22.05
Headlines
  • Fed Slows Pace Of Bond Buying To $5B Per Day From $6B Per Day
  • ECB Signals June Stimulus With Swift Recovery Ruled Out
  • IMF Says Banks Face Profitability Challenge Through 2025
  • BoE To Phase Out Some Emergency COVID Support
  • Italy Extends Maturity Of State-Guaranteed Loans For Smaller Firms
  • UK, Canada, Australia Deeply Concerned At China's HK Security Proposals
  • US Treasury’s New 20-Year Bond Is A Hit, Outperforming 30-Year
  • US Raises Ante In Vaccine Race With $1.2 Bln For Astra
  • Nokia First Of Big Three Vendors To Join Open RAN Policy Coalition
  • France Warns Renault Could Disappear; Nissan Plans Job Cuts
  • UK Court Throws Out Nigerian Oil Corruption Case Against Shell, Eni
  • IBM Is Cutting 'Several Thousand' Jobs
Commentary
Peking Uni-Led Research Team In China Might Pave Way For Potent COVID-19 Treatment To Stop Pandemic

As the world remains in almost a standstill and silenced after being ravaged by the novel coronavirus, scientists worldwide are sprinting to find solutions by researching vaccines and therapeutics. A Chinese research team spearheaded by Peking University (PKU) is taking the lead by unsheathing neutralizing antibodies, which will likely lay the foundation for potent COVID-19 treatment that would hopefully be available as early as this winter, in case of a resurgence of the virus.

 

The research team led by Sunney Xie, the director of the Beijing Advanced Innovation Center for Genomics at PKU, has successfully identified multiple highly potent neutralizing antibodies against the novel coronavirus SARS-CoV-2, the causative virus of the respiratory disease COVID-19, from convalescent plasma by high-throughput single-cell sequencing.

 

Such a drug would hopefully be able to stop the COVID-19 pandemic, in case the vaccine isn't available soon, Xie said in an exclusive interview with the Global Times on Wednesday. (Global Times – Continue Reading)

Files & Links
LIVESQUAWK PREVIEWS/REPORTS
DATA
GOVERNMENT/CENTRAL BANK NEWS
FIXED INCOME NEWS
FX NEWS
ENERGY/COMMODITY NEWS
EQUITY NEWS
EMERGING MARKET NEWS